Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen
Open Access
- 1 December 2001
- journal article
- case report
- Published by American Society of Hematology in Blood
- Vol. 98 (12) , 3486-3488
Abstract
Angiogenesis is required for tumor growth and metastasis. It has recently been suggested that thrombin is a potent promoter of angiogenesis. We therefore examined the possibility that thrombin could be inducing the expression of angiopoietin-2 (Ang-2), necessary for remodeling. Human umbilical vein endothelial cells were incubated with or without thrombin (1 U/mL) for 1 to 24 hours and then examined for messenger RNA (mRNA) by Northern analysis. Enhanced mRNA expression (about 4-fold over baseline) was noted at 4 hours. Enhanced expression of Ang-2 mRNA was secondary to enhanced transcription (about 4-fold), with no effect on stabilization. Enhanced Ang-2 mRNA transcription was inhibited by H7 and PD98059, indicating the requirement of serine/threonine kinases as well as the mitogen-activated protein kinase pathway. Up-regulation of mRNA was associated with enhanced Ang-2 protein synthesis and secretion as assayed by immunoblot. Thrombin-induced secreted Ang-2 inhibited the binding of recombinant 35S–Ang-1 to its Tie-2–Fc receptor, demonstrating functionality. Hirudin reversed this effect, demonstrating thrombin specificity. Thus, thrombin-induced tumorigenesis and metastasis is associated with enhanced Ang-2 protein synthesis and secretion via enhanced transcription of Ang-2. This could help explain how thrombin promotes angiogenesis.Keywords
This publication has 40 references indexed in Scilit:
- Evaluation of an Automated Technique for Assessment of Marrow Engraftment After Allogeneic Bone Marrow Transplantation Using a Commercially Available KitAmerican Journal of Clinical Pathology, 2000
- Expression of Angiogenesis Stimulators and Inhibitors in Human Thyroid Tumors and Correlation with Clinical Pathological FeaturesThe American Journal of Pathology, 1999
- Structure, Expression and Receptor-Binding Properties of Novel Vascular Endothelial Growth Factors1999
- Cell Type-Specific Expression of Angiopoietin-1 and Angiopoietin-2 Suggests a Role in Glioblastoma AngiogenesisThe American Journal of Pathology, 1998
- Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.Journal of Clinical Oncology, 1998
- Hematologic engraftment and reconstitution of immune function post unrelated placental cord blood transplant in an adult with acute lymphocytic leukemiaLeukemia Research, 1998
- Significance of Vascular Endothelial Growth Factor/Vascular Permeability Factor for Solid Tumor Growth, and Its Inhibition by the AntibodyBiochemical and Biophysical Research Communications, 1993
- Thrombin stimulates melanoma tumor‐cell binding to endothelial cells and subendothelial matrixInternational Journal of Cancer, 1993
- Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitroBiochemical and Biophysical Research Communications, 1992
- Abnormalities of blood coagulation in patients with cancer: Fibrinopeptide a generation and tumor growthCancer, 1983